These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9725467)

  • 1. Preparation and dissolution rate of gliquidone-PVP K30 solid dispersions.
    Martnez P; Goñi MM; Cantera RG; Martin C; Dios-Viéitez C; Martínez-Ohárriz C
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):113-7. PubMed ID: 9725467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30.
    Thybo P; Pedersen BL; Hovgaard L; Holm R; Mullertz A
    Pharm Dev Technol; 2008; 13(5):375-86. PubMed ID: 18720236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of solid dispersions of carvedilol with PVP K30.
    Sharma A; Jain CP
    Res Pharm Sci; 2010 Jan; 5(1):49-56. PubMed ID: 21589768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supercritical antisolvent versus coevaporation: preparation and characterization of solid dispersions.
    Majerik V; Horváth G; Szokonya L; Charbit G; Badens E; Bosc N; Teillaud E
    Drug Dev Ind Pharm; 2007 Sep; 33(9):975-83. PubMed ID: 17891584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles.
    Mohamed MS; Abdelhafez WA; Zayed G; Samy AM
    AAPS PharmSciTech; 2019 Dec; 21(2):35. PubMed ID: 31879830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Opposed Effects of Polyvinylpyrrolidone K30 on Dissolution and Precipitation for Indomethacin Supersaturating Drug Delivery Systems.
    Wang W; Li M; Yang Q; Liu Q; Ye M; Yang G
    AAPS PharmSciTech; 2020 Mar; 21(3):107. PubMed ID: 32185564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.
    Tapas A; Kawtikwar P; Sakarkar D
    Acta Pol Pharm; 2012; 69(2):299-308. PubMed ID: 22568045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and dissolution studies of fast release diclofenac sodium tablets from PVP solid dispersions.
    Lamas MC; Leonardi D; Lambri OA; Bassani G; Barrera MG; Bolmaro RE; Salomon CJ
    Pharm Dev Technol; 2010; 15(2):162-8. PubMed ID: 19589124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30).
    Damian F; Blaton N; Desseyn H; Clou K; Augustijns P; Naesens L; Balzarini J; Kinget R; Van den Mooter G
    J Pharm Pharmacol; 2001 Aug; 53(8):1109-16. PubMed ID: 11518020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.
    Smikalla MM; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Apr; 66(1):106-12. PubMed ID: 17055711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
    Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.